HepZero:Heparin Free Dialysis With Evodial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 265 participants.

Also called NCT01318486

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 265 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01318486
Other papers using this trial's data
  • Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis Kidney international, 2014-12 DOI, PubMed 25007166

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Canada, France, Netherlands, Poland, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01318486. Randomized; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2013-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
HepZero:Heparin Free Dialysis With Evodial
Condition
Patients Requiring Heparin Free Dialysis Treatments
Intervention (Other)
Heparin free dialysis technique
Intervention (Device)
Evodial
Lead sponsor
Vantive Health LLC (class: industry)
Collaborator
Statistical Analysis : CIC CHU Brabois Nancy (class: not stated)
Collaborator
Gambro Lundia AB (class: industry)
Collaborator
Baxter Healthcare Corporation (class: industry)

Record details

Record id
cardio:ct-nct01318486
Content hash
ebe941c3dca131fe605ab11b4a57c4097885cfeed22b0eb1ef89f9103075cf70